CSB: An Emerging Actionable Target for Cancer Therapy
- PMID: 29506668
- DOI: 10.1016/j.trecan.2018.01.005
CSB: An Emerging Actionable Target for Cancer Therapy
Abstract
The DNA repair protein Cockayne syndrome group B (CSB) is frequently found overexpressed in cancer cells. High CSB levels favor tumor cell proliferation whilst inhibiting apoptosis. Conversely, the suppression of CSB has significant anticancer effects. In this manuscript we describe CSB downregulation as a potential new therapeutic approach in cancer.
Keywords: Cockayne syndrome B protein; ER stress; cancer therapy; hypoxia; p53; transcription coupled repair.
Copyright © 2018 Elsevier Inc. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous